Earendil Labs-preview

Earendil

Earendil Labs

Private

Wilmington, DelawareHealthcare & Life Scienceshttps://earendil.bio/

Last Round

Early Funding

3/20/2026

Total Funding Raised

$861.8M

Company Overview

Earendil Labs is a biotechnology company that develops an AI-driven platform for biologics discovery and development to treat autoimmune diseases and cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Infrastructure

Keywords

AI drug discoverytechbioprotein therapeuticsbiologics discoverydrug discovery platformcomputational protein designprotein design AIgenerative biologyhigh-throughput biologyclosed-loop discoverypharmaceutical partnershipsbispecific antibodiesautoimmune disease therapeuticsoncology therapeuticsanti-TL1A antibody

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Earendil Labs Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Earendil Labs Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Early Funding	3/20/2026
Series A	6/22/2022

View all Funding Rounds

Earendil Labs Investors

Notable investors and investment history

Investor	Rounds
DST Global	Early Funding
Biotech Development Fund	Early Funding
Dimension	Early Funding
渶策资本	Early Funding
GL Ventures	Series A
5Y Capital	Series A
Luminous Ventures	Early Funding

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 2, 2026
Partnered with Helixon Therapeutics to advance therapeutic programs using AI.

View all signals

Earendil Labs Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Earendil Labs Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Earendil Labs's valuation, stock price, and market status.

Firmographic Details

HeadquartersWilmington, Delaware

Year Founded2024

Last Funding3/20/2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

Login

Use CasesInvestors Employees

CompaniesAll Companies

LegalPrivacy Policy Terms of Use BrokerCheck Form CRS

DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.